title: [Anti-aging or better aging: a contribution to the prevention of aging?].
abstract: Anti-aging wants to influence the quality of the second half of life so that chronic damage to health can also be prevented at a higher age with a good quality of life. Thus, molecular biological tests should become the basis for an individualized, preventive hormone therapy. In this context, the question arises whether for each woman in the menopause a risk profile of disturbances of hormone metabolism can already be recognized in her pattern of polymorphisms, although scientific evidence has been lacking until now. Even the topic of the adrenopause, which--among other features--is characterized by an age-specific, partial adrenal insufficiency, must not be neglected in the context of the problem of anti-aging.
authors.forename: U
authors.initials: U
authors.lastname: Haller
authors.forename: H
authors.initials: H
authors.lastname: Hepp
authors.forename: R
authors.initials: R
authors.lastname: Winter
mesh_terms: D000375:Aging / Q000187:drug effects / Q000235:genetics*; D003687:Dehydroepiandrosterone / Q000008:administration & dosage / Q000097:blood; D005260:Female; D005820:Genetic Testing; D006728:Hormones / Q000008:administration & dosage*; D006801:Humans; D008593:Menopause / Q000187:drug effects / Q000235:genetics
chemical_list: D006728:Hormones; D003687:Dehydroepiandrosterone